Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT06051227

Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial

Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2025-01-30

608

Participants Needed

1

Research Sites

111 weeks

Total Duration

On this page

Sponsors

A

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Lead Sponsor

S

Stichting ZiektekostenVerzekering Krijgsmacht

Collaborating Sponsor

AI-Summary

What this Trial Is About

Fentanyl and esketamine are both standard of care for treatment of acute severe traumatic pain in the prehospital setting in the Netherlands. However, it is not known whether they are equally effective and safe. It is also not known whether intranasal (IN) administration of fentanyl or esketamine is equally effective and safe as intravenous (IV) administration. The FORE-PAIN trial is a double-blind multi-arm randomized non-inferiority trial comparing Fentanyl IN, esketamine IV and esketamine IN (intervention arms) to fentanyl IV (comparator arm) for prehospital management of traumatic pain. The investigators hypothesize that all intervention arms provide analgesia that is non-inferior to the comparator arm, and that all study arms are equally safe.

CONDITIONS

Official Title

Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Pain caused by trauma occurring on the same day
  • Emergency Medical Services personnel determine that strong opioid or esketamine analgesia is needed
  • Patient will be transported to a hospital
Not Eligible

You will not qualify if you...

  • Estimated weight less than 40 kg or more than 100 kg
  • Does not understand Dutch or English
  • Unable to report pain score
  • Unable to receive intranasal or intravenous medication
  • Known severe cardiovascular disease
  • Pre-eclampsia
  • Glasgow Coma Scale score less than 11
  • Previously declined participation in medical research

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ambulance Amsterdam

Amsterdam, Netherlands

Actively Recruiting

Loading map...

Research Team

R

Robert P Weenink, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here